Evidence map›Paper›PMID 33472487›Full record

ArticleThe Journal of international medical research2021

A case of reversible splenial lesion syndrome secondary to Fanconi syndrome with white matter swelling as the main manifestation.

Jingzhe Han, Yaye Wang, Yue Wu, Jinru Zhang, Xueqin Song, Guang Ji

Open access · goldAbstract readCase Reports
In one paragraph

Article in The Journal of international medical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jingzhe HanDepartment of Neurology, Harrison International Peace Hospital, Hengshui, Hebei, China.ORCID https://orcid.org/0000-0002-6086-7533
Yaye WangDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Yue WuDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Jinru ZhangDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Xueqin SongDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.ORCID https://orcid.org/0000-0003-0463-8450
Guang JiDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Hebei Medical University · CNHarrison International Peace Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reversible splenial lesion syndrome (RESLES) is a rare clinical imaging syndrome that is characterized by magnetic resonance imaging (MRI) findings of reversible abnormal signals in the splenium of the corpus callosum (SCC). There are a variety of pathogenic causes, including infection, metabolic disturbances, and antiepileptic drug use. Moreover, the disease is clinically rare and easily misdiagnosed. Here, we report a unique case of a 32-year-old man with Fanconi syndrome who had an intensified signal in the SCC and diffuse white matter swelling on MRI. We believe this to be the first adult case of RESLES as a manifestation of Fanconi syndrome, which further expands the disease spectrum leading to RESLES. The imaging features of this case included extensive lesions, symmetrical diffuse restricted signals, and reversibility. The identification of these features improves our understanding of the imaging characteristics of RESLES, thus enabling clinicians to better understand this disease, correctly establish its diagnosis, and improve its prognosis in this kind of patient.

Indexed as

Brain DiseasesFanconi SyndromeWhite MatterAdultCorpus CallosumHumansMagnetic Resonance ImagingMalecentral nervous system symptomcorpus callosumFanconi syndromeimaging featuresmagnetic resonance imagingReversible splenial lesion syndrome

Identifiers

PMID33472487
PMCPMC7838877
OpenAlexW3121261396

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.